KARAS ERIC (Chief Commercial Officer) sold 59.3% of their position (15K shares) of ARS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $254.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/3/2025ACC: 0001415889-25-019321
Officer· Chief Commercial Officer
Since Nov 2022
-15K
Net shares
Net seller
$254.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$1.50
Trade value
$22.50K
% of position
145.4%
7/1/2025
10.31K→25.32K
Common Stock
Direct
Shares
−15K
Price / share
$16.99
Trade value
$254.86K
% of position
59.3%
7/1/2025
25.32K→10.31K
Total
Net shares
+0.00
Net value
-$232.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2025 | M · Option Exercise | +15K | $1.50 | $22.50K | 145.4% | 10.31K | 25.32K |
| Common Stock Direct | 7/1/2025 | S · Sale | −15K | $16.99 | $254.86K | 59.3% | 25.32K | 10.31K |
| Total | +0.00 | -$232.36K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
1.50
Held after
544.59K
Exercisable
—
7/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 7/1/2025 | M · Option Exercise | −15K | 1.50 | — | 544.59K |